Optimized Rivastigmine Nanoparticles Coated with Eudragit for Intranasal Application to Brain Delivery: Evaluation and Nasal Ciliotoxicity Studies

Rivastigmine, a reversible cholinesterase inhibitor, is frequently indicated in the management of demented conditions associated with Alzheimer disease. The major hurdle of delivering this drug through the oral route is its poor bioavailability, which prompted the development of novel delivery appro...

Full description

Saved in:
Bibliographic Details
Main Authors: Mansi Bhanderi, Jigar Shah, Bapi Gorain, Anroop B. Nair, Shery Jacob, Syed Mohammed Basheeruddin Asdaq, Santosh Fattepur, Abdulhakeem S. Alamri, Walaa F. Alsanie, Majid Alhomrani, Sreeharsha Nagaraja, Md. Khalid Anwer
Format: article
Language:EN
Published: MDPI AG 2021
Subjects:
T
Online Access:https://doaj.org/article/a9a7af170d3740dbb93f81d5536f7331
Tags: Add Tag
No Tags, Be the first to tag this record!